Abolghasem Jouyban*, Djavanshir Djozan, Parastou Mohammadandashti, Aliakbar Alizadeh-Nabil, Hooshangh Ghorbanpour, Maryam Khoubnasabjafari, Mohammad Mohammadzadeh
|
Arash Hajizadeh Dastjerdi, Hossein Behboudi, Zahra Kianmehr, Ali Taravati, Mohammad Mehdi Naghizadeh, Sussan Kaboudanian Ardestani*, Tooba Ghazanfari*
|
Sajad Khiali , Afra Rezagholizadeh , Taher Entezari-Maleki*
In the present perspective piece, three possible mechanisms of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as an oncogenic virus in the lung have been discussed.
|
Ata Mahmoodpoor , Ali Shamekh, Sarvin Sanaie*
|
Qiang Yang , Lei Li , Zhaohui Liu* , Chunlei Li , Lili Yu , Yulin Chang
The protective effects of PHC were absent in Nrf2-/- mice. PHC ameliorated RIR-induced lung injury by activating Nrf2 pathway.
|
Zhaohui Liu* , Yanli Meng, Yu Miao, Lili Yu, Qiannan Yu
Our findings could suggest the use of AS for treating lung disorders through a mechanism involving SIRT1 expression.
|
Fatemeh Ganji , Marzieh Ebrahimi, Ali Shirani, Mahtab Golmohammadi, Mazaher Gholipourmalekabadi, Maryam Kashanian, Kiana Koolaeinezhad, Hamid Reza Davari, Seyed Ali Javad Mousavi, Hamid Reza Aghayan, Babak Arjmand, Ramin Heshmat, Nushin Karkuki Osguei, Ali Samadikuchaksaraei*
|